376 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
retention policy requires the company’s Section 16 officers to hold either six, three or two times their base salary until satisfaction of the respective
8-K
EX-4.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
and in the Indenture prescribed.
As provided in the Indenture and subject to the satisfaction of certain conditions therein set forth, including the deposit … and in the Indenture prescribed.
As provided in the Indenture and subject to the satisfaction of certain conditions therein set forth, including
8-K
EX-5.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
or otherwise identified to our satisfaction, of such documents, corporate records and other instruments as we have deemed necessary for the purposes
8-K
EX-1.1
y6xz76ww4
22 Feb 24
Other Events
4:15pm
424B5
1dl1v65
16 Feb 24
Prospectus supplement for primary offering
4:34pm
SC TO-T/A
ctlx5 bkzdfsaj
16 Feb 24
Third party tender offer statement (amended)
11:36am
424B2
j8mpdn
13 Feb 24
Prospectus for primary offering
8:00am
8-K
EX-99.2
8bs3cs79
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
8-K
EX-99.1
x7q ishyn
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
ax33yfdwaqnsu9te6c5
25 Jan 24
Third party tender offer statement
8:13am